Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

Anath C. Lionel; Ashwath Gurumurthi; Ahmed Fetooh; Rami Eldaya; Sairah Ahmed; Swaminathan P. Iyer; Loretta J. Nastoupil; Jason Westin; Ranjit Nair; Luis Fayad; Luis Malpica; Sudhakar Tummala; Christopher Flowers; Sattva S. Neelapu; Michael L. Wang; Preetesh Jain

doi:10.1080/10428194.2024.2304622

Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

Anath C. Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P. Iyer, Loretta J. Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpica, Sudhakar Tummala, Christopher Flowers, Sattva S. Neelapu, Michael L. Wang, Preetesh Jain

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	669-673
Number of pages	5
Journal	Leukemia and Lymphoma
Volume	65
Issue number	5
DOIs	https://doi.org/10.1080/10428194.2024.2304622
State	Published - 2024

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2024.2304622

Cite this

Lionel, A. C., Gurumurthi, A., Fetooh, A., Eldaya, R., Ahmed, S., Iyer, S. P., Nastoupil, L. J., Westin, J., Nair, R., Fayad, L., Malpica, L., Tummala, S., Flowers, C., Neelapu, S. S., Wang, M. L., & Jain, P. (2024). Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement. Leukemia and Lymphoma, 65(5), 669-673. https://doi.org/10.1080/10428194.2024.2304622

Lionel, AC, Gurumurthi, A, Fetooh, A, Eldaya, R , Ahmed, S , Iyer, SP, Nastoupil, LJ, Westin, J , Nair, R , Fayad, L , Malpica, L, Tummala, S, Flowers, C , Neelapu, SS , Wang, ML & Jain, P 2024, 'Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement', Leukemia and Lymphoma, vol. 65, no. 5, pp. 669-673. https://doi.org/10.1080/10428194.2024.2304622

@article{6b0ada7246ce49b59ceabe3172cae5b3,

title = "Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement",

author = "Lionel, {Anath C.} and Ashwath Gurumurthi and Ahmed Fetooh and Rami Eldaya and Sairah Ahmed and Iyer, {Swaminathan P.} and Nastoupil, {Loretta J.} and Jason Westin and Ranjit Nair and Luis Fayad and Luis Malpica and Sudhakar Tummala and Christopher Flowers and Neelapu, {Sattva S.} and Wang, {Michael L.} and Preetesh Jain",

year = "2024",

doi = "10.1080/10428194.2024.2304622",

language = "English (US)",

volume = "65",

pages = "669--673",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "5",

}

TY - JOUR

T1 - Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

AU - Lionel, Anath C.

AU - Gurumurthi, Ashwath

AU - Fetooh, Ahmed

AU - Eldaya, Rami

AU - Ahmed, Sairah

AU - Iyer, Swaminathan P.

AU - Nastoupil, Loretta J.

AU - Westin, Jason

AU - Nair, Ranjit

AU - Fayad, Luis

AU - Malpica, Luis

AU - Tummala, Sudhakar

AU - Flowers, Christopher

AU - Neelapu, Sattva S.

AU - Wang, Michael L.

AU - Jain, Preetesh

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85182803433&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182803433&partnerID=8YFLogxK

U2 - 10.1080/10428194.2024.2304622

DO - 10.1080/10428194.2024.2304622

M3 - Letter

C2 - 38248629

AN - SCOPUS:85182803433

SN - 1042-8194

VL - 65

SP - 669

EP - 673

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 5

ER -

Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this